Systemic Lupus Erythematosus - Pipeline Review, H2 2015

1
Systemic Lupus Erythematosus - Pipeline Review,
H2 2015
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
2020
TELEPHONE [phone]E-MAIL
sales_at_researchbeam.com
Published on Oct 2014
2


Report Overview

• Scope
• The report provides a snapshot of the global
  therapeutic landscape of Systemic Lupus
  Erythematosus
• The report reviews key pipeline products under
  drug profile section which includes, product
  description, MoA and RD brief, licensing and
  collaboration details other developmental
  activities
• The report reviews key players involved in the
  therapeutics development for Systemic Lupus
  Erythematosus and enlists all their major and
  minor projects
• The report summarizes all the dormant and
  discontinued pipeline projects
• A review of the Systemic Lupus Erythematosus
  products under development by companies and
  universities/research institutes based on
  information derived from company and
  industry-specific sources Pipeline products
  coverage based on various stages of development
  ranging from pre-registration till discovery and
  undisclosed stages
• A detailed assessment of monotherapy and
  combination therapy pipeline projects
• Coverage of the Systemic Lupus Erythematosus
  pipeline on the basis of target, MoA, route of
  administration and molecule type Latest news and
  deals relating related to pipeline products
• Read More At http//www.researchbeam.com/systemi
  c-lupus-erythematosus-pipeline-review-h2-2015-mark
  et

3


Table of Content
Table of Contents 2List of Tables 7List of
Figures 9Introduction 10Global Markets Direct
Report Coverage 10Systemic Lupus Erythematosus
Overview 11Therapeutics Development 12Pipeline
Products for Systemic Lupus Erythematosus -
Overview 12Pipeline Products for Systemic Lupus
Erythematosus - Comparative Analysis 13Systemic
Lupus Erythematosus - Therapeutics under
Development by Companies 14Systemic Lupus
Erythematosus - Therapeutics under Investigation
by Universities/Institutes 19Systemic Lupus
Erythematosus - Pipeline Products Glance 20Late
Stage Products 20Clinical Stage Products
21Early Stage Products 22Systemic Lupus
Erythematosus - Products under Development by
Companies 23Systemic Lupus Erythematosus -
Products under Investigation by
Universities/Institutes 28Systemic Lupus
Erythematosus - Companies Involved in
Therapeutics Development 294SC AG 29AbbVie Inc.
30
4


Report Overview
Reasons to buy Provides strategically
significant competitor information, analysis, and
insights to formulate effective RD development
strategies Identify emerging players with
potentially strong product portfolio and create
effective counter-strategies to gain competitive
advantage Develop strategic initiatives by
understanding the focus areas of leading
companies Identify and understand important and
diverse types of therapeutics under development
for Systemic Lupus Erythematosus Plan mergers
and acquisitions effectively by identifying key
players of the most promising pipeline Devise
corrective measures for pipeline projects by
understanding Systemic Lupus Erythematosus
pipeline depth and focus of Indication
therapeutics Develop and design in-licensing and
out-licensing strategies by identifying
prospective partners with the most attractive
projects to enhance and expand business potential
and Scope Modify the therapeutic portfolio by
identifying discontinued projects and
understanding the factors that drove them from
pipeline Enquire At http//www.researchbeam.co
m/systemic-lupus-erythematosus-pipeline-review-h2-
2015-market/enquire-about-report
5



FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/systemic-lupus-erythem
atosus-pipeline-review-h2-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] DIRECT 1 (503)
894-6022E-MAIL sales_at_researchbeam.com